Cited by 300Antimicrobial Resistance in StaphylococcusStreptococcal Infections and TreatmentsOtolaryngology and Infectious Diseases

Comparison of Staphylococcus aureus from skin and soft-tissue infections in US emergency department patients, 2004 and 2008

Talan, D. A., Krishnadasan, A., Gorwitz, R. J., Fosheim, G. E., Limbago, B., Albrecht, V., Moran, G. J., for The EMERGEncy ID Net Study Group·2011·Clinical Infectious Diseases

Abstract

BACKGROUND: In the past decade, new methicillin-resistant Staphylococcus aureus (MRSA) strains have emerged as a predominant cause of community-associated skin and soft-tissue infections (SSTIs). Little information exists regarding trends in MRSA prevalence and molecular characteristics or regarding antimicrobial susceptibility profiles of S. aureus isolates. METHODS: We enrolled adults with acute, purulent SSTIs presenting to a US network of 12 emergency departments during August 2008. Cultures and clinical information were collected. S. aureus isolates were characterized by antimicrobial susceptibility testing, pulsed-field gel electrophoresis, and toxin genes detection. The prevalence of S. aureus and MRSA and isolate genetic characteristics and susceptibilities were compared with those from a similar study conducted in August 2004. RESULTS: The prevalence of MRSA was 59% among all SSTIs during both study periods; however, the prevalence by site varied less in 2008 (38%-84%), compared with 2004 (15%-74%). Pulsed-field type USA300 continued to account for almost all MRSA isolates (98%). Susceptibility to trimethoprim-sulfamethoxazole, clindamycin, and tetracycline among MRSA isolates remained greater than 90% in 2008. A higher proportion of MRSA infections were treated with an agent to which the infecting isolate was susceptible in vitro in 2008 (97%), compared with 2004 (57%). CONCLUSIONS: Similar to 2004, MRSA remained the most common identifiable cause of purulent SSTIs among patients presenting to a network of US emergency departments in 2008. The infecting MRSA isolates continued to be predominantly pulsed-field type USA300 and susceptible to recommended non-β-lactam oral agents. Clinician prescribing practices have shifted from MRSA-inactive to MRSA-active empirical antimicrobial regimens.

Integrity signals

Registry

Crossref · 10.1093/cid/cir308

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • S. aureus, in its methicillin sensitive and methicillin resistant form (MRSA), is a common opportunistic pathogen, responsible for the majority of all superficial skin infections, resulting in increased morbidity, mortality, and tremendous health-care costs.

    “S. aureus, in its methicillin sensitive and methicillin resistant form (MRSA), is a common opportunistic pathogen, responsible for the majority of all superficial skin infections, resulting in increased morbidity, mortality, and tremendous health-care costs [20].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Talan, D. A., Krishnadasan, A., Gorwitz, R. J., Fosheim, G. E., Limbago, B., Albrecht, V., Moran, G. J., & for The EMERGEncy ID Net Study Group
Affiliations
  • University of California, Los Angeles (US)
  • Centers for Disease Control and Prevention (US)
Venue
Clinical Infectious Diseases
Published
2011-06-20
Volume
53
Issue
2
Pages
144-149
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W2027912106
Cited by
300
References
25
Citations by year
2026: 5 · 2025: 7 · 2024: 11 · 2023: 10 · 2022: 13 · 2021: 24 · 2020: 17 · 2019: 17 · 2018: 20 · 2017: 25 · 2016: 32 · 2015: 33 · 2014: 26 · 2013: 35 · 2012: 22
FWCI
18.55
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Infectious Diseases (publishedVersion)
  • PubMed (publishedVersion)
Funders
Centers for Disease Control and Prevention (U01CK000176, U01CI000353)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Streptococcal Infections and Treatments
  • Health Sciences › Medicine › Infectious Diseases › Otolaryngology and Infectious Diseases
Keywords
methicillin-resistant Staphylococcus aureus, community-acquired MRSA, skin and soft tissue infections, USA300, antimicrobial susceptibility, pulsed-field gel electrophoresis typing, toxin genes, emergency department patients
MeSH terms
Adolescent, Adult, Aged, Aged, 80 and over, Anti-Bacterial Agents, Bacterial Toxins, Emergency Service, Hospital, Female, Genotype, Humans, Male, Microbial Sensitivity Tests, Middle Aged, Staphylococcal Skin Infections, United States, Prevalence, Cluster Analysis, Electrophoresis, Gel, Pulsed-Field, Community-Acquired Infections, Soft Tissue Infections, Methicillin-Resistant Staphylococcus aureus, Young Adult, Molecular Typing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review